Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/ EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up

Assessing the Sensitivity and the Clinical Impact of the 2023 American College of Rheumatology/ EULAR Classification Criteria in Obstetric Antiphospholid Syndrome: Findings From a Multicenter Italian Cohort With a Long‐Term Follow‐Up | ReachRx